Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Get Free Report) CAO Jonathan David Lanoy sold 5,000 shares of Nature’s Sunshine Products stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $20.45, for a total value of $102,250.00. Following the sale, the chief accounting officer owned 46,233 shares in the company, valued at $945,464.85. This represents a 9.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Nature’s Sunshine Products Trading Down 0.2%
Nature’s Sunshine Products stock traded down $0.05 on Thursday, hitting $19.82. 19,524 shares of the stock traded hands, compared to its average volume of 79,081. The business’s fifty day simple moving average is $15.98 and its 200 day simple moving average is $15.50. The firm has a market cap of $346.68 million, a P/E ratio of 26.78 and a beta of 1.09. Nature’s Sunshine Products, Inc. has a 1 year low of $11.01 and a 1 year high of $21.64.
Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.18. Nature’s Sunshine Products had a net margin of 3.06% and a return on equity of 10.19%. The company had revenue of $88.99 million during the quarter, compared to analysts’ expectations of $119.39 million. Nature’s Sunshine Products has set its FY 2025 guidance at EPS.
Institutional Investors Weigh In On Nature’s Sunshine Products
Analysts Set New Price Targets
Several brokerages recently commented on NATR. DA Davidson increased their price objective on shares of Nature’s Sunshine Products from $21.00 to $23.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Canaccord Genuity Group increased their price target on shares of Nature’s Sunshine Products from $21.00 to $22.00 and gave the company a “buy” rating in a report on Friday, August 1st. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Nature’s Sunshine Products in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $22.50.
Nature’s Sunshine Products Company Profile
Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Read More
- Five stocks we like better than Nature’s Sunshine Products
- How to Find Undervalued Stocks
- NVIDIA Just Proved the AI Boom Is Bigger Than Anyone Thought
- What is the Dogs of the Dow Strategy? Overview and Examples
- Why Target Stock May Keep Falling Despite a 5% Dividend Yield
- Health Care Stocks Explained: Why You Might Want to Invest
- Is Tesla Setting Up for a Year-End Rebound—or a Collapse?
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.
